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EVALUATING A DISCHARGE MEDICATION DELIVERY SERVICE: 
A RETURN ON INVESTMENT STUDY AND A PILOT TRIAL 
JONATHAN HATOUN 
ABSTRACT 
Background:  Many patients discharged from the hospital do not appropriately fill 
their discharge medications. At Boston Medical Center, an urban safety net facility, a 
bedside discharge medication delivery service was pilot tested in 2012 to ensure pediatric 
patients with asthma left in possession of their new medications.  The service was 
expanded to all pediatric discharges in 2013.  It is unknown whether beside delivery 
increases the proportion of written prescriptions captured by the hospital-owned 
pharmacy or if the service achieves a positive return on investment. Whether such a 
service improves patients’ satisfaction, medication adherence, or clinical outcomes is also 
unknown. 
Methods: Two primary methodologies were used to evaluate the impact of this 
novel service.  The first evaluated the relative risk of filling a prescription in the hospital-
owned pharmacy after the expansion of delivery eligibility criteria using two years of 
discharge prescription information, corresponding pharmacy fill data, and a hierarchical 
model with generalized estimating equations (GEE) to account for non-independent 
events.  Initial patient-level impacts of the delivery service were evaluated through a pilot 
randomized controlled trial to test logistics and obtain empiric estimates of study 
parameters. 
	  	   vi	  
Results: Patients were 1.44 times more likely to fill a medication at the hospital-
owned pharmacy providing the delivery service after the intervention (95%CI 1.3-1.59).  
The increased profit generated by prescriptions captured as a result of offering the 
delivery service is estimated to be equivalent to 8-15% of a pharmacist full-time-
equivalent (FTE), whereas only 3% of an FTE was required to provide the service, 
indicating a positive return on investment. Pilot study data suggest families did not differ 
significantly with regards to perceived satisfaction or reported outcomes whether 
randomized to usual care or delivery. 
Conclusion:  A service to deliver discharge medications can yield a positive return 
on investment, allowing an institution to offset uncompensated care. To further study the 
intervention, a trial with randomization at the level of the ward or institution is needed.	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INTRODUCTION 
 
Many patients discharged from the hospital do not appropriately fill their 
discharge medications.   Without the proper medications, patients are more likely to have 
adverse events and readmissions.  One approach to reducing these adverse events is to 
ensure that patients are discharged in possession of their discharge prescription 
medications.  Hospitals increasingly are offering services that ensure medication 
possession prior to discharge; however, linking traditionally outpatient services to the 
inpatient setting is challenging.  Inpatient disbursement of outpatient medications may 
improve clinical outcomes and is likely to be well received by patients because of its 
convenience; however, such a service may be costly for the pharmacy offering it.   
 Approximately four years ago, Boston Medical Center let its lease of its pharmacy 
services to an outside, for-profit group expire.  The non-profit medical center took over 
management of the pharmacy with a goal to maximize revenue over expenses from the 
provided pharmacy services.  The hospital administration saw this as an opportunity not 
only to improve the pharmacy experience for patients, but also to secure greater financial 
stability for the organization.  Given BMC’s status as a disproportionate share hospital, 
the outpatient pharmacy qualified for reduced wholesale medication pricing via the 340B 
legislation and pricing plan.   
Section 340B of the Public Health Service Act was enacted in 1992 and 
establishes ceiling prices on outpatient drugs for certain hospitals and other programs that 
dispense medications to patients.  Hospitals qualify for these price ceilings if they are 
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owned, operated, or under contract with state or local governments, and if they are 
considered a Disproportionate Share Hospital (DSH).  DSH signifies that a certain 
percentage of patients served by the hospital are Medicare or Medicaid insured1.  
 DSH Patient Percent = (Medicare SSI Days / Total Medicare Days) + 
(Medicaid, Non-Medicare Days / Total Patient Days) 
 
 Most drugs provided in the outpatient setting are eligible for 340B pricing, 
including over the counter drugs when a prescriber writes a prescription.  Vaccines and 
medical devices are not covered.  Once a pharmacy arranges a 340B account with a 
wholesaler they can negotiate additional discounts (below the federal ceiling price) which 
can lower the cost of drugs to approximately 50% of the average wholesale price 
available to non-340B pharmacies.   
With the potential to increase margins for the hospital because of the profitability 
of the outpatient pharmacy, the administration hired pharmacy directors skilled in 
analytics, optimization, and pharmacy economics, and who shared in the mindset of the 
safety net hospital’s goal to provide “exceptional care without exception.” 
 An effort was initiated to increase the use of the hospital-owned pharmacy by 
patients of the hospital, and to “win-back” some of those patients who had taken their 
business to off-campus pharmacies.  As part of that effort, the pediatric ward engaged 
with pharmacy management to create an expedited medication filling service for pediatric 
patients being discharged, along with many other efforts.  Experience from this initiative 
has helped to produce numerous programs currently in place that promote the use of the 
hospital-owned pharmacy to patients.   
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The ongoing efforts in no way restrict patients from using any other pharmacy; 
however, the services offered are designed to provide a greater level of convenience for 
patients than alternative options for filling medications.  For example, pediatric patients 
seeing their primary care physician in the outpatient clinic can have their new 
prescriptions prepared and ready for pickup by the time most patients have taken the 
elevator to the ground floor reach the pharmacy.   
 Another service, and the focus of this thesis, removes any need for a family 
member of an admitted pediatric patient to pickup medications at a pharmacy – even the 
hospital-owned outpatient pharmacy.  Instead, a pharmacist from the hospital’s outpatient 
pharmacy can be activated to prepare and deliver discharge prescriptions rapidly to 
patient rooms before they are discharged.  Such a service allows a family whose life 
recently has been turned upside down by their child’s admission to the hospital to leave 
the hospital after discharge without having to stop at the pharmacy on the way home.  
Medical teams are able to provide discharge teaching with the actual medications in-
hand, and can rest assured that all insurance barriers have been resolved prior to 
discharge and that their patients have their medications.  The convenience of this service, 
named “Meds-in-Hand,” likely increases the chances that the family fills their 
prescriptions.  Though possession of medication is not a guarantee that the patient will 
take the medication as prescribed, a discharge medication delivery service is at least the 
first step towards ensuring adherence to the medical plan.  
 Under the right circumstances, the Meds-in-Hand service can benefit patients as 
well as the pharmacy and hospital.  Prescriptions written by physicians at BMC that 
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would otherwise be filled at an outside pharmacy may be filled more frequently by the 
BMC-owned outpatient pharmacy providing the delivery service.  Any margins 
associated with these increased transactions are likely to be augmented by the discounted 
purchase prices authorized with 340B pricing.   
 The delivery service, referred to as “Meds-in-Hand” was initially piloted in 
September of 2012 only for those pediatric patients admitted for an asthma exacerbation. 
These patients are considered at the highest risk for “bounce-back” if they do not fill their 
prescriptions after discharge.  Regardless of the cost of the service, the pharmacy and 
inpatient teams agreed that it was worth ensuring that these patients were discharged 
from the hospital in possession of their medications.  On June 1st 2013, after repeated 
improvements in the delivery mechanism, the service was expanded and became 
available to all patients being discharged from the pediatric ward.   
This expansion meant that any patient being discharged Monday through Saturday 
(the pharmacy is closed on Sundays) could receive their medications delivered to the 
bedside by a pharmacist and therefore could avoid a trip to an outside pharmacy after 
discharge.  The expansion was driven by the strong support of physicians, nurses, and 
families who had experienced the Meds-in-Hand service. Pharmacy agreed to the 
expanded service having recently hired additional staff, but without a full cost assessment 
of the expanded service.  
Certainly, the delivery service is an additional task for pharmacists.  Traditionally, 
patients arrive at the pharmacy front desk; pharmacists do not need to walk across the 
hospital to find a particular patient in their room.  While time spent delivering 
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medications certainly represents an increased cost to the hospital over routine care, this 
inefficiency may not be financially crippling to a pharmacy providing the service. If the 
service is attractive enough to eligible users, the increased transaction volume and its 
associated revenue may be enough to offset the cost of this service reasonably. As such, 
the return on investment study described below is essential to assess whether a similar 
service can be implemented elsewhere within the hospital or at other similar institutions.  
In order to fully leverage the 340B medication pricing status of the hospital-
owned outpatient pharmacy, the introduction of the medication delivery service would 
have to generate an increase in the number of prescriptions filled by the pharmacy at least 
to cover the cost of the additional pharmacist time needed to provide the service.  While 
the non-profit hospital may continue to perform the service out of altruism, this would be 
antithetical to our hospital’s goal to use the pharmacy as a revenue-enhancing department 
that supports other ongoing and costly endeavors.  
 In general, pharmacies consider their “capture rate” to be the proportion of 
prescriptions written by doctors for patients being discharged from the hospital that are 
filled at the hospital pharmacy.  In order to make a business case for the additional cost of 
pharmacist time outside of pharmacy delivering medications, one must show that the 
proportion of prescriptions “captured” increases as a result of the delivery service being 
implemented or expanded.   
The determination of whether or not there is a positive return on investment is 
particularly important at a safety net hospital where opportunities to increase revenue 
may allow for the greater provision of uncompensated care.  Similarly, though, any new 
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service that is not margin generating, will likely be offered only at the expense of 
another.  The 340B medication pricing plan that BMC qualifies for is a form of 
legislative subsidy granted as a result of the hospital’s safety net status.  Lowered 
wholesale purchase pricing potentiates the profitability of the pharmacy service.  
The Congressional Budget Office released a paper in 2006 to study the impact of 
health-related legislative tax breaks and how forgone government revenues may or may 
not promote hospitals providing the intended community benefits.  The authors 
recognized that legislative exemptions are a form of government subsidy that may 
promote the provision of public goods2.  Public goods are those goods that are non-rival 
and non-excludable.  For example, an individual receiving uncompensated care will not 
only benefit directly, but so too might the providers of that care (by having their 
compassionate impulses fulfilled) or other members of the community (by having a 
communicable disease treated).  In general, it is believed that managers of non-profit 
organizations are more willing than managers of for-profit organizations to provide 
public goods when doing so is unprofitable.  The paper from the Congressional Budget 
Office found that on average, non-profit hospitals provided more uncompensated care 
than for-profit hospitals, though the provision of uncompensated care varied widely3. 
Reduced operating costs create larger margins, which can allow for greater 
profits.  However, most hospitals are non-profit organizations, therefore abiding by the 
“non-distribution constraint” such that no one may make a legal claim on the residual2.  
During times of financial success, non-profits therefore can offer a greater menu of 
services for their community and those in need.  Yet during times of financial pressure, 
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non-profit hospitals often have to diversify their offerings as a means to greater 
profitability and financial sustainability4.  Such diversification has been speculated to 
redirect hospitals from their traditional roles and responsibilities, including charity care.  
Legislation can provide the incentives necessary to keep hospitals focused on their goals 
to provide care to the most needy. 
The 340B legislation regarding pharmacy prescription medication cost, is one 
example of legislation intended to promote caring for those individuals whose care may 
be considered too costly to a for-profit operation.  Passage of the 340B legislation serves 
as recognition by lawmakers of two key realities faced by hospitals treating large 
proportions of patients insured by Medicaid and Medicare.  The first is that 
reimbursement from Medicaid or Medicare for services and prescriptions is lower than 
reimbursement from private insurers.  The second, a consequence of the first, is that 
many hospitals may be less motivated to care for patients insured by the government, 
effectively restricting access to services for those in need.  Both of these problems are in 
some way addressed when the government allows hospitals designated as DSH to 
purchase medications below average wholesale price.   
By allowing for a lower purchase price, the legislation effectively generates 
greater returns for the pharmacy.  Additionally, those hospitals on the cusp of qualifying 
for DSH may be more inclined to increase their proportion of patients who would help 
them qualify for DSH in order to lower their costs.  A hospital benefiting from 340B 
purchase pricing may better serve its patients with a greater number of services because 
of increased pharmacy returns.    
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If run efficiently, the outpatient pharmacy department can become an important 
source of revenue for safety-net or other non-profit hospitals.  Pharmacies with 340B 
status would likely be encouraged by their institutions to increase their transaction 
volume via patient outreach, efficient disbursement methods, and other creative 
initiatives.  The result of greater volume in pharmacy is greater earnings that can fund 
other charitable care throughout the organization, presuming they are made available to 
the hospital.  Consistent with the findings of the Congressional Budget Office review, the 
340B legislation has the potential to financially motivate the provision of uncompensated 
care.   
Unprofitable departments of a hospital are routinely scrutinized for their utility in 
the face of financial losses.  Some researchers focused on supply chain optimization have 
suggested that hospitals “need to eliminate unprofitable departments that are not 
regulated by law.”5  In reality, profitable departments frequently “cover for” those 
departments with less financial solvency.  Without this re-distribution of profit, the 
provision of much charitable care would likely cease. 
Given the net potential benefits of the provision of public goods, more research is 
needed examining how federally funded initiatives can promote community benefit.  
However, it is likely extremely difficult to show that a department-specific tax break, 
which can benefit the solvency of the entire hospital, is directly responsible for the 
continued provision of another, uncompensated service at that hospital.  Movement of 
profits within a hospital is not widely discussed and rarely made public.  Still, one can 
assume that any profit-generating interventions aimed at non-profit institutions will allow 
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for a greater capacity to provide other services, barring extreme operational 
inefficiencies.  
In general, this work is situated within the theoretical understanding that safety 
net hospitals, or those providing uncompensated care, generally attempt to maximize 
their provision of uncompensated care.  However, they may only do so to the point where 
their marginal revenue is balanced by the marginal cost of uncompensated care6.  As 
discussed above, marginal revenue in one division may have “spillover” effects in 
another, thus facilitating a greater provision of uncompensated care.  
While the profits returned from providing a discharge medication delivery service 
may exceed the costs of providing such a service, a delivery service also has the potential 
to impact patient perceptions of their care substantially as well as impact patient reported 
outcomes.  
Parental satisfaction with the care delivered during a child’s hospitalization is an 
important measure of quality that contributes to the patient experience and can determine 
how hospitals are ranked publically and how they are reimbursed7,8. Parents commonly 
report dissatisfaction about discharge planning communication, with nearly a quarter of 
parents feeling unprepared to give medications or monitor for adverse effects of 
medications following hospital discharge9. Improving the system of discharge medication 
preparedness has the potential to enhance parental satisfaction with hospital care and 
improve patient outcomes after discharge. 
The current standard of care for most pediatric inpatient units requires families to 
fill their child’s prescriptions at an outside pharmacy, potentially causing added stress 
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around the time of discharge. In addition, this practice does not address parents’ desire to 
discuss the purpose, side effects, and proper administration of medications during the 
hospitalization10. Delivery of medications to the bedside prior to discharge by an 
outpatient pharmacist may provide an opportunity to improve the patient experience and 
patient outcomes.  
Meds-in-Hand was developed when pediatric providers at BMC discovered that 
30% of their patients with asthma reported not having filled their new prescriptions 48 
hours after discharge – a proportion supported by the literature.11,12  There are numerous 
social, financial, and health literacy barriers that confront BMC patients when they try to 
adhere to their treatment plans. Meds-in-Hand attempts to remove some of the barriers 
these families face when obtaining their medications to improve their children’s health 
after discharge.   
A small cohort of children admitted for an asthma exacerbation, for whom 
insurance claims data were readily obtained were analyzed for their healthcare utilization 
in the period immediately after discharge. In this non-randomized, observational cohort, 
it was demonstrated that compared to children admitted with an asthma exacerbation 
receiving usual care, children who received Meds-in-Hand had a significantly reduced 
odds of re-presentation to the Emergency Department within 30 days of discharge 
(OR=0.18, 95%CI [0.047-0.99]; manuscript accepted by Pediatrics). These encouraging 
observational data are hypothesis generating and led to the design and implementation of 
a randomized pilot study, described below, to inform the planning of a future, more 
definitive, multi-site randomized controlled trial to determine the effectiveness of Meds-
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in-Hand.  
The specific aims of the pilot study were to: (1) Field-test key logistical aspects of 
studying a discharge medication delivery service (“Meds-in Hand”) versus usual care in a 
randomized fashion for patients admitted with an asthma exacerbation – including 
recruitment approaches, the willingness of parents to consent to a randomized trial, 
intervention fidelity, group-to-group cross-over, and the collection of follow-up data 
related to the patient experience and parent-reported health outcomes.  (2) Obtain empiric 
estimates of key study parameters to inform future study design. These include within-
group standard deviation of continuous outcome measures; proportion of control group 
subjects who obtain their medications promptly; and correlation of repeated measures. (3) 
Assess for possible trends in study outcomes between groups, with the understanding 
that, as a pilot study, it is not necessarily powered to detect differences.  
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METHODS 
Return on Investment 
The study of the change in the proportion of prescriptions captured as a means to 
determining the return on investment from a discharge medication delivery service was 
granted approval by the Institutional Review Board at Boston University Medical Center.  
Boston Medical Center’s Clinical Data Warehouse generated a list of all non-surgical 
patients discharged from the pediatric ward from August 1, 2012 to September 30, 2014.  
These dates allow for data to be analyzed for approximately one year prior to the 
expansion of the Meds-in-Hand service (and the historical limit of accurate pharmacy 
records necessary for this study) and 14 months after the expansion.   
The pharmacy routinely determines all the prescriptions written by the inpatient 
teams for discharged patients at Boston Medical Center in aggregated monthly reports.  
These reports were used to determine all the non-surgical pediatric discharge 
prescriptions over the time period of interest by cross-referencing medical record 
numbers (MRN) and discharge dates with the list of discharged patients obtained from 
the clinical data warehouse.  This list of written prescriptions contained all the 
prescriptions that may have been filled at the hospital-owned pharmacy, a private 
pharmacy, or not filled at all and would serve as the basis for the denominator of the 
proportion of captured prescriptions over any time interval. 
In order to determine the numerator, that is, those prescriptions filled by the BMC 
outpatient pharmacy (or those prescriptions that BMC “captured”), pharmacy records of 
disbursed prescriptions were cross-referenced against the list of written discharge 
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prescriptions.  Since prescriptions could be disbursed prior to the day of discharge via the 
Meds-in-Hand service, the numerator list included those prescriptions filled after the day 
of admission but before the day of discharge.  Additionally, medications that were written 
during an admission and were filled up to five days after discharge were included in the 
numerator list for the capture rate, as occasionally families do not fill prescriptions 
immediately after discharge, and instead return to the pharmacy in the days after 
discharge.  
Within those prescriptions counted as “captured” were both those prescriptions 
filled by the Meds-in-Hand delivery service with those prescriptions filled by families 
who visited the pharmacy in person.  However, distinguishing which medications were 
disbursed by the Meds-in-Hand service is essential to understanding if the expansion of 
the delivery service to all patients was an attractive enough service to convince patients 
who would have otherwise filled their medications at another pharmacy to opt to use the 
delivery service.  Certainly some patients who would have otherwise visited the BMC-
owned outpatient pharmacy in person would be considered even more likely to take 
advantage of the Meds-in-Hand service.  Statistical methods described below were used 
to attempt to determine if the delivery service is simply substituting those patients who 
would have otherwise gone down to the pharmacy in person to pickup their medications 
for patients receiving the delivery service, or if it is indeed generating new filled 
prescriptions because of its utility.  
While the above methods of determining the proportion of prescriptions captured 
deal with the vast majority of prescriptions, it is possible that prescriptions that were 
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either faxed or called into pharmacy were not included in the denominator.  Given our 
methods to source written and filled prescriptions, however, it was possible to see any 
filled prescription associated with a patient’s discharge that was filled, even if the 
prescription did not appear in the denominator list.  As such, we assumed that any filled 
prescription not already included in the denominator list was phoned in and an entry was 
created in the denominator file to reflect this.  
Since the beginning of the delivery service, the BMC pharmacy also maintained a 
log of all delivered medications. This log was accessed to determine the number of 
deliveries and medications per delivery before and after the expansion of the service.  
Additionally, this list was cross-referenced with the numerator and denominator lists and 
any medications appearing on the delivery log that were not otherwise accounted for had 
entries created for them on those lists. 
Two statistical approaches were used to determine the impact of the expansion of 
Meds-in-Hand.  All computations were performed using SAS 9.3 (SAS Institute, Cary, 
IN).  First, generalized estimating equations (GEE) were used to account for non-
independence in the data, given that an individual with multiple prescriptions is more 
likely to fill a prescription at a particular pharmacy if another prescription was also filled 
there13.  Clustering was accounted for at the level of the individual by discharge date. The 
primary outcome was whether or not a prescription was filled at the BMC pharmacy and 
the independent variable was whether or not the patient was admitted prior to or after the 
intervention.  The relative risk of having a prescription filled at BMC (versus filled 
anywhere else or not filled) was determined using a log link binomial distribution.  
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Prior to obtaining the data from pharmacy, the research team planned to censor 
the two months of data immediately after the intervention given that quality improvement 
efforts had previously shown these months to be a “ramp up” period to full use of the 
expanded Meds-in-Hand service.  Additional testing was performed by also eliminating 
any prescription written for a patient discharged on a Sunday, as the pharmacy is not 
open on Sundays.  Bivariate analyses as well as adjusted analyses were performed.  
Adjustment for age, race, and sex of the patient – the available demographic 
characteristics in the dataset – produced a final model.   
A second approach to analyzing the same data utilized an interrupted time series 
approach.  The interrupted time series approach allows for determination of a statistically 
meaningful change in both the immediate changes associated with the intervention 
(intercept shift) and changes in the trend of filling patterns (slope)14.  In order to utilize 
this strategy, however, data was aggregated over weekly time intervals, causing a loss of 
information about the individual associated with each prescription (clustering) as well as 
demographic information (adjustment).  This aggregation of data to obtain weekly 
proportions of prescriptions filled was performed only after determining that there were 
no statistically meaningful changes in age, sex, or race in the population prior to and after 
the intervention.  We used an autoregressive form of a regression model14 given that 
residents on the pediatric ward rotate every four weeks and that a theoretical learning 
curve exists prior to achieving full use of the Meds-in-Hand service.  A lag time of four 
weeks was incorporated into the model.  An analysis of annual seasonality effects also 
was performed.  
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In order to assess the increased margins resulting from the expansion of the Meds-
in-Hand program two primary strategies were used.  First the relative risk of filling a 
prescription from the GEE model was applied to the number of prescriptions filled at 
pharmacy during the post period to determine the difference in predicted prescription fills 
and observed fills.  This difference may represent the new prescriptions filled that would 
not have previously been filled at the BMC pharmacy.  Additionally we used pharmacy 
logs of all delivered medications to determine the mean number of deliveries to the ward 
as well as the mean number of prescriptions delivered at weekly intervals both before and 
after the intervention.  Understanding that some delivered prescriptions may have 
previously been filled at the pharmacy regardless of whether the Meds-in-Hand service 
had been expanded, we tested various proportions of the difference in the mean number 
of prescriptions when estimating a profit margin attributable to the service.  
Using pharmacy records the “calculated margin” per prescription was derived by 
subtracting the total compensation for a given prescription from the acquisition costs.  
However, given that these values are frequently misleading in the pharmacy records 
because of common exceptions such as the uncompensated provision of goods and 
services for individuals lacking insurance, waived co-pays, or other adjustments, a 
“predicted margin” is often used in pharmacy calculations.  The predicted margin is 
calculated by taking 45% of the total registered compensation for a medication.  Across 
all disbursed medications at the BMC pharmacy, the mean predicted margin per 
prescription is approximately $32, though this is not specific to pediatric medications.  
The additional cost of providing the service was calculated as the time lost in 
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pharmacy due to the delivery of medications.  Because of continuous improvement 
efforts to streamline the delivery service, delivery of a medication via the Meds-in-Hand 
process relies upon many of the same pharmacy processes that a routine medication 
utilizes.  The overlapping steps include initial prescription processing, medication 
preparation and labeling, medication teaching, administration demonstration (if 
necessary), and payment exchange.  The only additional step required by BMC 
pharmacists was the transit time walking from the outpatient pharmacy to the pediatric 
ward.  In order to determine the mean time lost, 50 consecutive deliveries were timed 
from the time of departure from the pharmacy to the time of return to pharmacy.  In order 
to determine the mean transit time, all routine (non-delivery) transactions also were timed 
at the pharmacy throughout an afternoon time period when most deliveries are brought to 
patients on the ward via the Meds-in-Hand service.  The routine time was subtracted from 
the total time out of pharmacy.   
Using the information gained from the cost analysis as well as the profit analysis, 
a determination of the return on investment was performed.  A full time equivalent (FTE) 
for a pharmacist was used as reference and with a value determined in discussion with a 
pharmacy manager accounting for full fringe benefits.  Profits associated with an 
expanded delivery service were calculated in terms of the percentage of a pharmacist 
FTE, and costs providing the Meds-in-Hand delivery service were calculated similarly.  
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Randomized Pilot Study 
In addition to the study of the profitability of the Meds-in-Hand delivery service, 
a randomized pilot study was performed.  The study was approved by the Institutional 
Review Board at Boston University Medical Center and was funded in part by a grant 
from the Joel and Barbara Alpert Endowment for Children of the City.  Parents of 
patients aged 2-17 admitted to the pediatric ward for an asthma exacerbation were 
eligible for the study. Parents were the exclusive subjects in the study, though eligible 
patients assented to their involvement.   
A research team member monitored the recent admissions to the ward daily for 
any patients in the appropriate age range with a primary diagnosis of asthma 
exacerbation.  After discussing the study and its potential ramifications with the medical 
team caring for the patient, a research assistant would approach the eligible family 
member to discuss consent and enrollment.  Of note, doctors and nurses were allowed to 
say that a family was not a reasonable candidate for the study for various medical, social, 
or other reasons.  Total admission counts were recorded and information available from 
the medical record was recorded for all eligible patients.  
Consented patients were asked a brief, in-hospital survey regarding basic 
demographic information as well as a recent history of the child’s asthma.  The patient of 
the subject was then randomized in a 1:1 manner to either receiving “usual care” or 
Meds-in-Hand.  The usual care group would have prescriptions sent to their preferred 
pharmacy.  The randomization did not change the actual medications patients receive, but 
how and when they are disbursed: either by a member of the hospital-owned pharmacy 
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delivering them via the Meds-in-Hand service or at the pharmacy location of the subject’s 
choosing after discharge. Crossover between the two groups was confirmed by 
comparing pharmacy records of medications delivered via the Meds-in-Hand service and 
the assigned arm of the study.  
 Follow-up phone calls were then initiated at three and 30 days after discharge.  
Records were maintained of how many call attempts were necessary to reach patients.  
Questions in the three-day call survey were largely based on the CAHPS Child Hospital 
Survey published by the AHRQ15, with questions selected from this larger survey in order 
to focus the interview on discharge preparedness. Additional questions regarding health 
care utilization and current health status were asked. 
The 30-day interview focused on interim patient-reported outcomes, including 
health care utilization, missed school days, and other functional outcomes.  The Asthma 
Control Test16 was also asked given its focus on symptoms over the prior month. Patients 
were thanked with a $25 gift card to a national retail store for completing the three-day 
phone survey and with a $10 gift card to the same store for completing the shorter 30-day 
phone survey.   
Analysis of the pilot study data included descriptive statistics of demographic 
characteristics, comparisons of dichotomous outcomes with Chi-Squared testing, and 
comparisons of continuous outcomes with the T-Test.  Non-enrolled eligible families 
were also compared similarly. A visual representation of the admission tracking, 
enrollment, and followup for the pilot study is depicted in Figure 1.  All data were 
collected and managed using REDCap (Research Electronic Data Capture).  
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Figure 1. Randomized pilot study schematic. 
The two studies were distinct in time. That is, the data studied for the return on 
investment portion of the research did not overlap with the timing of the pilot RCT.  
Thus, patients randomized to usual care in the pilot study would not artificially reduce the 
capture proportion in the return on investment analysis.   	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RESULTS 
Return on Investment 
 The available demographic characteristics of the sample analyzed can be seen in 
Table 1. There were 6590 prescriptions written for patients being discharged from the 
pediatric service during the study, 4088 of which were filled by the BMC pharmacy for 
2206 different individuals.  While all covariate information was available for most of the 
individuals filling prescriptions at the BMC pharmacy there were 507 individuals with at 
least one missing demographic variable.  
 
Overall Cohort (N=2206) 
Gender (%)  
 Male 51.8 
 Female 48.2 
Age in years (%)  
 0-4 54.7 
 5-9 14.8 
 10-14 8.0 
 15-19 12.0 
 20+ 10.4 
Race (%)  
 Black/African American 47.7 
 Hispanic/Latino 28.7 
 White 11.8 
 Other* 11.3 
 Declined 0.6 
*Other=Asian, Middle Eastern, or “Other” 
Table 1. Sample characteristics of cohort analyzed for return on investment study. 
 
Across the sample, there were significant differences in the race and age of the 
family that filled a prescription at the hospital owned pharmacy.  Table 2 shows that a 
greater proportion of Black/African Americans and “Other” races used the hospital-
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owned pharmacy in some capacity, whereas more Whites did not use the pharmacy as 
much (p < 0.001).  The mean age of patients with any utilization of the hospital-owned 
pharmacy across the cohort was 9.3 years, while the mean age of patients not using the 
pharmacy was 10.3 years (p <0.01), though this difference has little clinical meaning.  
 
Race Use Hospital Pharmacy Don’t Use Hospital Pharmacy 
Black/African American 56.3 43.7 
Hispanic/Latino 50.1 49.9 
White 39.5 60.5 
Other 61.3 38.7 
 
Table 2. Proportion of patients using the hospital-owned pharmacy in any capacity across 
the sample analyzed. 
 
 There were no significant differences in racial distribution, gender distribution, or 
mean age of the sample in the time period prior to the intervention compared to those in 
the time period after the intervention.  Figure 2 shows the similar distributions of age in 
those patients utilizing the hospital-owned pharmacy both before and after the 
intervention.  
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Figure 2. Age of patients using the pharmacy before and after the intervention.   
 
The raw counts of prescriptions written for patients being discharged that were 
filled at the BMC pharmacy are seen in Figure 3.  The proportion of prescriptions 
captured by the BMC pharmacy is seen in Figure 4. The mean proportion of prescriptions 
captured prior to the intervention was 0.51, while the mean proportion of prescriptions 
captured after the intervention was 0.69.  Figure 5 shows the raw counts of total 
prescriptions written (gray) as well as the count of prescriptions disbursed via the Meds-
in-Hand delivery service (yellow) and by traditional pickup methods at the pharmacy 
(blue). 
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Figure 3. Raw counts of discharge prescriptions filled at the hospital-owned pharmacy. 
 
 
Figure 4. Proportion of discharge prescriptions filled at the hospital-owned pharmacy 
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Figure 5. Raw counts of discharge prescriptions written with hospital-owned pharmacy 
disbursement method overlaid. 
 
Generalized Estimating Equations 
 Patients were 1.44 (95% CI: 1.30-1.59) times more likely to fill a prescription at 
the BMC pharmacy after the intervention than prior to the intervention when accounting 
for clustering at the level of the individual by discharge date and when adjusting for age, 
sex, and race.  Bivariate and multivariate modeling on an uncensored data set as well as 
on a data set that not only eliminated all the prescriptions from the two months after the 
intervention, but also all prescriptions written for patients discharged on Sundays 
(because the pharmacy is closed on Sundays and the delivery service was not available) 
revealed no major changes in the model result.  Bivariate and multivariate model results 
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are shown in Table 3.  A table of relevant output from the bivariate and multivariate GEE 
models for the full data, the censored data sets, and a data set with all Sunday’s deleted in 
addition to the routine censoring is available in Appendix A.  
 Bivariate (p-value) Multivariate (p-value) 
Post -0.375 
(<0.001) 
-0.363 (<0.001) 
Age  -0.006 (<0.001) 
Sex (F)  -0.096 (0.04) 
Race   
  Other (0)  0.373 (<0.001) 
  Black (1)  0.301 (0.001) 
  Hispanic (2)  0.197 (0.039) 
  White (3)  Ref. 
   
Relative Risk (95%CI) 1.456 (1.31-1.62) 1.438 (1.30-1.59) 
 
Table 3. Output from bivariate and multivariate GEE modeling on the primary dataset 
 
Interrupted Time Series 
 An auto-regressive approach to fitting pooled data at the weekly level revealed no 
significant auto-regressive terms using a lag time of 4 weeks.  While three auto-
regressive terms were included in the analysis assessing for seasonal variability (nlag = 
52) the time intervals between these terms were nonsensical with respect to the seasons 
and these results were therefore excluded.  A statistically significant increase in the 
intercept of the fitted lines for the data prior to and after the intervention was noted 
(coefficient: 0.1144, p=0.05) and no change in the slope between the two lines was noted 
(coefficient: -0.0031, p=0.12).  A graphical representation of the intercept shift can be 
seen in the fitted lines from the model output in Figure 6 
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Figure 6. Interrupted time series approach: fitted regression lines demonstrating an 
intercept shift. 
 
Margin Analysis 
 Using the calculated relative risk of having a prescription filled at pharmacy after 
the intervention as compared to before the intervention of 1.4555, a predicted count of 
filled prescriptions can be calculated for the post-intervention period under the 
assumption that the intervention not been implemented.  Using the known fill counts after 
the intervention, it is predicted that approximately 900 prescriptions were filled in the 70 
weeks after the Meds-in-Hand expansion as a result of the intervention (12.86 more 
prescriptions per week). 
An alternative calculation of the increase in delivered prescriptions per week 
attributable to the expansion of the delivery service using the change in observed means 
yields similar results.  Prior to the expansion of the delivery service (the intervention) 
there were 5.6 deliveries from pharmacy per week, delivering and average of 20.2 
prescriptions per week (3.6 prescriptions/delivery).  After the intervention there were 
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13.6 deliveries from pharmacy each week, delivering 33.9 prescriptions per week (2.5 
prescriptions/delivery).  Thus, after the intervention, 13.7 more prescriptions were 
observed to be filled per week as a result of deliveries. 
 The calculated margin ($18.80) and the predicted margin ($20.97) per 
prescription were similar throughout the study period.  The salary and fringe costs of a 
full time (1 FTE) pharmacist at BMC is $144,144.  Table 4 shows the calculated annual 
percentage of a pharmacist FTE gained via the margins derived from the increased 
prescriptions based on various calculated and predicted margins per prescription.   
 
  Percent of pharmacist FTE salary paid for by increased 
prescriptions 
Margin Margin 
Value 
($) 
Using relative risk-
derived script 
increase (12.86) 
Assuming every 
observed script 
would not have 
otherwise been 
filled (13.7)  
Assuming half of 
observed scripts 
would not have 
otherwise been 
filled (6.85) 
Calculated 18.80 8.7% 9.3% 4.6% 
Predicted 20.97 9.7% 10.4% 5.2% 
Pharmacy 
Mean 32.00 14.8% 15.8% 7.9% 
Table 4. Percent of pharmacist FTE generated based on various inputs. 
 The mean time for delivery was 13 minutes. The mean time for an over-the-
counter transaction was four minutes.  The calculated “time lost” in pharmacy as a result 
of an average delivery is 9 minutes.  Given that 8 more deliveries were executed per 
week after the intervention, the average per week time lost in pharmacy was 72min [= 
9min/delivery x 8deliveries], or 3% of the 40 hour work week (approximately $4,300).  
Even at the lowest margin per prescription and assuming only 50% of the increased 
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deliveries are newly captured by the pharmacy, the service returns a greater percentage of 
an FTE than it costs.   
 Table 5 calculates the profitability of a similar medication delivery service under 
various conditions, which might occur at another hospital.  Assuming a full time FTE for 
a pharmacist costs $150,000, the figure can be interpreted based on the time out of 
pharmacy lost for making a single delivery, the average profit margin per prescription 
filled, the number of prescriptions per delivery, and the total number of new prescriptions 
delivered via the service each week.  An outpatient pharmacy manager whose pharmacy 
is close to the ward to which deliveries will go would look at the top row of colored 
images as these represent average transit times of 10 minutes.  A pharmacy with 304B 
pricing might look towards the lowest row in any given graphic, as this represents an 
average margin of $30/prescription, while a pharmacy with higher costs may be closer to 
only $5 profit per prescription. Next a manager would need to assess the mean 
prescriptions per discharged patient.  If each discharged patient is only receiving one 
medication, each delivery becomes more “costly” (left column of graphics), whereas if 
patients are routinely discharged with multiple medications, efficiency is created (right 
column of graphics). Lastly, depending on the overall volume of the hospital and 
pharmacy on a per-week basis, an estimate of the cost of or profit from such a service can 
be determined.   
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Table 5. Profit and loss estimates for implementing a Meds-in-Hand-like service based on time for delivery, margin per 
prescription, prescriptions per delivery, and the total predicted increase in prescriptions filled.	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 30 $18,700 $37,400 $56,100  30 $24,950 $49,900 $74,850  30 $28,700 $57,400 $86,100 
               
   1     2     5  
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  30 -$6,300 -$12,600 -$18,900  30 $12,450 $24,900 $37,350  30 $23,700 $47,400 $71,100 
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Randomized Pilot Study 
 While a positive return on investment strongly supports the sustainability of any 
intervention, the impacts of the program on patient satisfaction and on clinical outcomes 
are best determined with a randomized trial.  The results of a pilot study beginning to 
examine these important consequences are now detailed. 
A summary of eligible admissions and whether or not they enrolled in the study 
can be seen in Figure 7.  A relatively low number of admissions for asthma during the 
study period (compared to prior years) as well as medical team preferences limited the 
enrollment to below the expected number of subjects at study outset.  Medical team 
refusal to allow patients which they deemed “at risk” to be randomized resulted in 9 
potential families not being approached.  The success of reaching patients for the three-
day and 30-day calls can be seen in Figure 8. 
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Figure 7.  Enrollment opportunities February to March, 2015. 
 
 
Figure 8. Follow-up phone call success at three- and thirty-days. 
 
666	  Ward	  Admissions 
63	  Asthma	  Admissions
603	  Non-­‐Asthma	  (91%) 
51	  Eligible 12	  Ineligible	  (19%) (5	  age,	  4	  language,	  2	  enrolled,	  1	  no	  scripts) 
31	  Approached 20	  Not	  Approached	  (39%) (9	  Medical	  team	  
23	  Enrolled 8	  Refused	  (26%) (4	  no	  interest, 	  3	  prefer	  home	  pharmacy,	   1	  without	  phone) 
23	  enrolled 12	  Meds-­‐in-­‐Hand 11	  Usual	  Care 11	  Reached	  for	  3-­‐day	  Call 8	  Reached	  for	  3-­‐day	  Call8	  Reached	  for	  30-­‐day	  Call 9	  Reached	  for	  30-­‐day	  Call 
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 A review of those subjects not answering calls for the three- and 30-day follow-up 
calls did not reveal any consistent trend in the characteristic of non-responders.  While all 
non-responders were female and most were black or African American this distribution is 
consistent with the sample.  Amongst non-responders, there was an even mix of 
education levels, employment, marital status, number of adults in the home, and number 
of children in the home.  Of note, the two subjects who responded to the three-day call 
but not the 30-day call spoke primarily Spanish at home.  
Table 6 shows pertinent information regarding the study subjects, while Table 7 
reveals the reported characteristics of the admitted family’s home, and Table 8 
demonstrates characteristics of the children admitted to the hospital. 
 
Characteristic  
Mean Age (yrs) 34.8 (22-63) 
Hispanic (%)  39% 
Race  
 Black 61% 
 White 13% 
 Unknown 22% 
Female 91% 
Single 48% 
Education  
 Some High School 26% 
 Graduated High School 39% 
 Some College 17% 
Employed 59% 
Unemployed and not looking 18% 
Benefits  
 WIC 43% 
 SNAP (Food Stamps) 30% 
 Housing Voucher 4% 
Have cell phone 91% 
Table 6. Characteristics of parents or guardians enrolled in the study. 	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Mean adults in the home 2.1 
Mean children in the home 2.2 
Primary language in the home  
 English 74% 
 Spanish 22% 
At least one smoker lives at home 35% 
 Smoker only smokes outside 60% 
Asthma triggers  
 Hairy pets 35% 
 Carpets 23% 
 Cockroaches 17% 
 Rats/Mice 39% 
Table 7. Characteristics of the homes of children whose parents or guardians were enrolled. 
 
Male 57% 
Median age (yrs) 6.13 
Median BMI (percentile) 80 
Prescribed a controller medication 74% 
Asthma managed by   
 Primary Care 61% 
 Pulmonologist 30 
Medicaid insured 75% 
Median school days missed in last 30 2 
Median MD visits for asthma in last year 2 
Median ER visits for asthma in last year 2 
Median Hospitalization for asthma in last year 1 
Table 8. Characteristics of the children admitted whose parents or guardians were enrolled. 
 
 With regards to the fidelity of the randomization assignment and the intervention, 
only one patient assigned to the Meds-in-Hand group did not appear on the pharmacy 
delivery log.  Interestingly, all patients in the Meds-in-Hand group verbally confirmed 
having received all their medications prior to discharge, however.  Two patients 
supposedly assigned to the usual care group appeared on the pharmacy delivery list.  
These two occurrences of crossover were early in the study, and steps were taken to 
ensure no further crossover.  No similar events were noted after the sixth enrolled subject.  
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 Comparisons of the responses to all questions in the three-day call can be seen in 
Appendix B.  While the comparisons are not statistically significant given the limited 
sample size for these analyses, some findings generate further hypothesis testing for a 
larger study.  There appears to be no impact of the service on overall satisfaction, 
perceptions of privacy, or the severity of patients’ symptoms shortly after discharge.  
While not significantly different, there were more missed school days in the Meds-in-
Hand group than those receiving usual care.  Still, 82% of the study sample receiving 
Meds-in-Hand agreed that a provider asked if the parent had any concerns about their 
child’s readiness to leave the hospital, while only 50% of those patients receiving usual 
care methods of prescription disbursement felt similarly.  
 The majority of subjects opted not to answer the open-ended questions posed by 
the survey.  However those that did clearly seemed to value the delivery service highly.  
One patient in the Meds-in-Hand arm noted: “It was easier and more accommodating 
getting the medications before leaving the hospital.”  Two patients from the usual care 
arm seemed disgruntled with having to pickup their medications in the traditional 
manner:  “Why didn't they give us delivery [which I had on a prior admission]?  That's a 
really good service - its hard to get medications and they should offer it to anyone;” “I 
was downstairs in the hospital pharmacy to pick up the medication; I would have liked 
when they drop off the medications in the room and I can ask questions privately; I also 
had to leave my daughter by herself in the room when I get the medications and I didn't 
like that. Other than that things were great.”  
 Comparisons of the all the responses to the 30-day call can be seen in Appendix 
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C.  It is notable that a month after discharge, five patients receiving usual care had had 
two or more primary care visits, while only two patients receiving Meds-in-Hand had a 
similar number of appointments (p=0.04).  The only re-visit to an ER and the only re-
admission within 30 days occurred in the Usual Care arm of the study, though difference 
was not statistically significant.  There were no meaningful differences in the overall 
reported health of the patients, though families in our cohort reported more missed school 
days from the Meds-in-Hand group.  This finding, though is likely attributable to a single 
outlier patient.  With regards to medication pickup, only one patient reported difficulty 
obtaining their medications, and they were in the Usual Care arm.  No patients receiving 
Meds-in-Hand appeared to have difficulty refilling their medications – a theoretical 
concern of the intervention 
 Though the pilot study did not demonstrate significant effects of the Meds-in-
Hand program on patient satisfaction measures or parent-reported clinical outcomes, it 
was not powered to be able to do so.  Additionally, given the limited enrollment during 
the study period, interpretations of any comparisons of the two arms should be made 
extremely cautiously.  The most significant finding from the pilot study is the low rate of 
enrollment of eligible candidates due to medical team refusal, suggesting a high face-
validity to the intervention.  Once the Meds-in-Hand service is available on a particular 
ward, it seems likely that providers will attempt to use it as much as possible.  This 
finding suggests significant contamination is likely to occur were a future study to 
randomize at the level of the individual.  Though trials utilizing randomization at the unit 
level or at the hospital level are likely to be more costly, the finding of a likely positive 
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return on investment for hospitals and pharmacies successfully implementing the 
intervention should motivate such research going forward.  	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DISCUSSION 
  
Delivering discharge medications to the bedside has the potential to be a rare 
“win-win” in healthcare.  We have shown that under the conditions present at our safety 
net hospital, which has access to 340B wholesale pharmacy pricing, the margins 
generated from new prescriptions filled at the pharmacy as a result of an expanded 
delivery service were enough to pay for the day-to-day costs of the service.  Start-up 
costs were not able to be determined given the already functioning pilot program at our 
institution; however, apart from administrative meetings and brief training sessions, there 
likely is relatively little cost to the initiation of a similar service elsewhere.  The one item 
purchased by pharmacy to facilitate the delivery service was a mobile credit card 
payment device.  This item was purchased to ensure that co-payments could be accepted 
in a patient’s room similarly to how they might be accepted in pharmacy.  No complex 
training regimens were required. 
If a positive return on investment was seen while operating the service on a small 
pediatric ward, expansion of the service to an adult ward is likely to generate even greater 
profits.  Hospitalized adult patients are often discharged on more medications and those 
medications tend to return a greater margin per prescription to the pharmacy and hospital.  
Of course, expanding the service to multiple wards may lengthen transit time, introduce 
logistical difficulties, or require additional staffing, all of which could be costly.   
Still, the calculations above do not consider the possibility of the service 
successfully capturing refill medications that would have otherwise been filled at another 
pharmacy had the original prescription been filled elsewhere.  Whether from the mail 
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delivery service described above or simply from patients returning to the hospital 
pharmacy to pickup refills, the increased capture of discharge prescriptions is likely to 
also have a lasting impact on increased refill prescriptions.  Due to the limitations of the 
databases from which the data in this study were derived, it was not possible to accurately 
count refills filled at the BMC-owned pharmacy that were attributable to a discharge 
prescription.  Without this information, however, the total earnings reported above are 
likely an underestimate, only further adding to the conclusion that the intervention 
yielded a positive return on investment.  Additional revenue from refills can be 
considered equivalent to increasing the number of prescriptions per delivery in Table 5. 
It is possible that a non-pharmacist staff member can deliver certain medications.  
The use of lower-cost employees to implement the delivery service would certainly 
augment the return on investment for a similar delivery service at another institution.  
While regulations may require the presence of a licensed pharmacist at medication 
disbursement and the ability to answer detailed questions may be compromised, the use 
of alternative staff models can certainly be considered in the right environment.  
The Meds-in-Hand bedside delivery service also improves communication 
between the care team and patients with the goal of improving a patient’s understanding 
of their disease. By addressing this important problem in the quality of care delivered9, 
medical teams may be able to enhance patient experience, improve patient care in the 
transition from the hospital to the home, and even reduce adverse events.  Not factored 
into the calculations in this analysis are the potential financial benefits that the hospital 
can receive by increasing its patient satisfaction scores, some of which increasingly are 
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tied to government reimbursement rates. 
While the randomized pilot study discussed here enrolled fewer patients than 
expected, many important lessons were learned regarding the implementation of such a 
study from the recruitment strategies, to the randomization mechanism, to the pattern of 
phone call follow-up.  While the statistical power was lacking to begin to draw 
conclusions about the differences between those patients receiving the Meds-in-Hand 
service and those receiving usual care, there are some encouraging patterns in the data 
that suggest patients receiving Meds-in-Hand are satisfied with their hospitalization and 
perform well from a clinical perspective after hospitalization. 
The return on investment study is not without its limitations. Because we were 
unable to determine those prescriptions that were called in to outside pharmacies, the 
denominator of our capture rate is likely to be biased towards a smaller number, 
potentially increasing the determined capture rate.  Determining an exact count for the 
denominator was unrealistic given that all pharmacies in the area could not be contacted 
to determine phoned in prescriptions for the relevant patients during the time period of 
interest. Nonetheless, the lost information associated with phoned prescriptions is 
unlikely to have a serious impact on the conclusions of the study. Phoned prescriptions 
represent a small overall percent of discharge prescriptions and are likely to have shifted 
similarly to electronically written prescriptions in their direction from outside pharmacies 
to the BMC-owned outpatient pharmacy. This potential loss of information therefore may 
affect the calculated proportion of prescriptions captured, but is unlikely to affect the 
change seen in the proportion captured.  
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The most important limitation of the pilot study was the limited enrollment of 
patients during the study. Low levels of enrollment and incomplete follow-up with all 
those patients enrolled negatively impacts the ability to reliably create empiric estimates 
of future study parameters or to begin to compare trends between the two groups.   
 As with every intervention, the delivery program itself has potential downsides. 
The most notable potential harm might occur under the scenario where a patient is 
prescribed a medication with refills, yet the BMC outpatient pharmacy is very difficult 
for that family to access for those refills, even as the initial medication is obtained more 
easily.  As such, the family would receive their first disbursement in their room prior to 
discharge, but then have to either come back to BMC to obtain a refill, or one month 
later, remember to call BMC to have the prescription transferred and activated at their 
home pharmacy. Under a worst-case scenario the family may then go days without 
necessary medication.  Additionally, patients may schedule visits to see primary care 
physicians, simply to coordinate having a refill sent.   
While the instance of such a worst-case scenario is likely to be rare, the team 
designing the intervention took special care to avoid such an outcome.  If a patient was 
delivered a medication and the prescription had at least one refill, pharmacists would first 
try to enroll the patient (or family) into the mail delivery service for all subsequent 
medication fills.  Like the in-room convenience of the Meds-in-Hand delivery service, a 
mail delivery service is also thought to offer great convenience to the patient.  Mail 
delivery also retains the earnings of future fills within the BMC-owned pharmacy.  If a 
patient or family was not eligible for or refused to have their refill medications filled by 
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the mail delivery service, the refills would be pro-actively “pushed” to the patient’s 
pharmacy of choice by the pharmacist. 
A larger randomized study of the patient perception of the Meds-in-Hand service 
should be performed at the level of the hospital ward or hospital.  This study found that 
when randomizing at the level of the patient, contamination was high, as many physicians 
and nurses intervened on behalf of their patients to ensure that the Meds-in-Hand service 
was activated.  These patients were typically considered high risk from either a medical 
or social perspective and providers were uncomfortable allowing for the potential for the 
patient to be randomized to usual care, if they could otherwise ensure the delivery of 
discharge prescriptions via the Meds-in-Hand service.  The high face-validity of the 
intervention prohibited clinicians from engaging with the researchers under the principle 
of clinical equipoise.  
A larger study of the intervention may be beneficial from an academic 
perspective.  Regardless, it is highly likely that the economic analysis showing a positive 
return on investment of an intervention with high face validity and which is highly 
appreciated by patients and providers is sufficient to promote its further installation at 
other institutions.  With the calculated table above, a hospital executive or pharmacy 
manager can estimate the profitability of such a service based on conditions at their 
institution.   
It is worth noting, that after expansion of the delivery service, the number of 
prescriptions per delivery dropped at our facility.  Prior to the expansion of the service, 
only those patients being discharged from a hospitalization for asthma were receiving 
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Meds-in-Hand.  These patients receive a standard bundle of at least three medications (a 
short acting beta agonist, an inhaled corticosteroid, and an oral steroid) in addition to any 
other necessary medications.  After the intervention, patients with fewer discharge 
prescriptions became eligible for delivery.  Given that many pediatric patients are not on 
numerous chronic medications, their discharge prescriptions are frequently for only one 
or two new medications. Careful consideration of local conditions must be taken before 
initiating such a service, as discharge medication packages differ greatly from one ward 
to another, from one institution to another.    
Also of note is the fact that the pediatric ward has a unique age distribution and 
reasons for admission to a pediatric ward are often highly discrepant from reasons for 
admission to an adult ward.  The biphasic trend seen in Figure 2, is commonly presumed 
to be related to patients with more chronic needs whose conditions progress over time, 
such that an increasing number of admissions to the pediatric ward occur when patients 
are in their early 20’s.  This increase in admissions happens at the same time that these 
patients become eligible for admission to an adult ward.   
A careful eye will note that an increasing percentage of delivered prescriptions 
were delivered to parents of children under two after the expansion of the delivery 
service.  While not significant enough to influence the mean meaningfully, we suspect 
that this small shift is related to a recognition of the fact that younger children are often at 
greater risk of sequelae from improperly treated disease.  Physicians and nurses may be 
more inclined to push for the Meds-in-Hand service to be implemented for this 
vulnerable population.  
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While some patients always will reject the delivery service with a preference for 
having prescriptions sent and filled at their local, home pharmacy, the opportunity to 
offer a convenient service to patients that simultaneously generates profits for the hospital 
should never be overlooked.  Knowing that post-discharge medication fills by patients are 
low11,12, and knowing that a hospital is at risk for not being reimbursed for any 
subsequent readmission, there is clear motivation for the discharging hospital team to 
take more significant ownership of a patient’s preparedness for discharge than previously 
done.  A service like Meds-in-Hand may be one way for hospitals to take greater 
ownership of their patient’s post-discharge health and to avoid significant penalties for 
adverse events. 
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APPENDIX A: Output from various GEE models and datasets 
 
 No Censoring Censor two months Censor two months and   
all Sundays 
 Bivariate 
(p-value) 
Multivariate 
(p-value) 
Bivariate  
(p-value) 
Multivariate 
(p-value) 
Bivariate  
(p-value) 
Multivariate 
(p-value) 
Post -0.346 
(<0.001) 
-0.333 
(<0.001) 
-0.375 
(<0.001) 
-0.363 
(<0.001) 
-0.469 
(<0.001) 
-0.388 
(<0.001) 
Age  -0.007 
(0.02) 
 -0.006 
(<0.001) 
 -0.008 
(0.005) 
Sex (F)  -0.104 
(0.03) 
 -0.096 
(0.04) 
 -0.067 
(0.13) 
Race       
  Other (0)  0.424 
(<0.001) 
 0.373 
(<0.001) 
 0.412 
(<0.001) 
  Black (1)  0.359 
(<0.001) 
 0.301 
(0.001) 
 0.271 
(0.002) 
  Hispanic (2)  0.258 
(0.008) 
 0.197 
(0.039) 
 0.192 
(0.037) 
  White (3)  Ref.  Ref.  Ref. 
       
Relative Risk 
(95%CI) 
1.414 
(1.27-1.57) 
1.400 
(1.26-1.55) 
1.456 
(1.31-1.62) 
1.438 
(1.30-1.59) 
1.493 
(1.35-1.66) 
1.474 
(1.33-1.63) 
 
	  	  
46	  
APPENDIX B: All comparisons for the three-day follow-up phone call 
Question Comment Statistical Comparison 
During the first day of this hospital stay, were you asked to 
list or review all of the prescription medicines your child 
was taking at home?  
 p = 0.71  
During the first day of this hospital stay, were you asked to 
list or review all of the vitamins, herbal medicines, and 
over-the-counter medicines your child was taking at home?  
Approx 1/3 of all subjects 
enrolled were not asked 
about these substances. 
p = >0.99 
During this hospital stay, how often did your child's nurses 
explain things in a way that was easy for your child to 
understand?  
 p = >0.99	  
During this hospital stay, how often did your child's nurses 
encourage your child to ask questions?  
Only two “never” responses 
registered and both in MiH 
group. 
p = >0.99	  
During this hospital stay, how often did your child's doctors 
explain things in a way that was easy for your child to 
understand?   
 p = 0.82	  
During this hospital stay, how often did your child's doctors 
encourage your child to ask questions?   
 p = >0.99	  
During this hospital stay, how often did your child's nurses 
explain things to you in a way that was easy to understand?   
 p = 0.74	  
During this hospital stay, how often did your child's nurses 
treat you with courtesy and respect?   
All responses “always” 	  
During this hospital stay, how often did your child's doctors 
explain things to you in a way that was easy to understand?   
 p = 0.74	  
During this hospital stay, how often did your child's doctors 
treat you with courtesy and respect?   
All responses “always” 
except for two “sometimes” 
p = >0.99	  
During this hospital stay, how often did providers involve 
you as much as you wanted in discussions about your child's 
health care?   
81% of MiH were “always” 
while 62% of UC were 
“always” 
p = 0.76	  
During this hospital stay, how often were you given as much 
privacy as you wanted when discussing your child's care 
with providers?   
No signal of loss of privacy 
for MiH, a theoretical 
concern 
p = >0.99	  
During this hospital stay, how often did providers talk with 
and act toward your child in a way that was right for your 
child's age?   
 p = >0.99	  
Sometimes people are treated in an unfair or insensitive way 
because of something about them or their family, like their 
race, income, religion, or some other thing. During this 
hospital stay, did providers or other hospital staff ever treat 
you or your child in an unfair or insensitive way? 
All responses “no” p = 	  
During this hospital stay, how often did providers keep you 
informed about what was being done for your child?   
No MiH response less than 
“usually,” though 2 UC 
responses as “sometimes” 
p = 0.27	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Before your child left the hospital, did a provider ask you if 
you had any concerns about whether your child was ready to 
leave?   
82% of MiH replied “yes 
definitely” while only 50% 
of UC replied “yes 
definitely.” Additionally, 
3/8 in UC replied “no.” 
p = 0.10	  
Before your child left the hospital, did a provider talk with 
you as much as you wanted about how to care for your 
child's health after leaving the hospital?   
Both arms strongly agreed 
they had been given enough 
information. 
p = >0.99	  
Before your child left the hospital, did a provider tell you 
that your child should take any new medicine that he or she 
had not been taking when this hospital stay began?  
¾ of the subjects replied 
“no” (despite all patients 
starting a new med). Only 1 
UC said “yes” and 4 MiH 
said “yes” 
p = 0.34	  
Before your child left the hospital, did a provider or hospital 
pharmacist explain in a way that was easy to understand 
how your child should take these new medicines after 
leaving the hospital?   
Since this question was 
based on prior, only 5 total 
responses, and all said yes 
	  
Before your child left the hospital, did a provider or hospital 
pharmacist explain in a way that was easy to understand 
about possible side effects of these new medicines?   
Same as above 	  
Before your child left the hospital, did a provider explain in 
a way that was easy to understand what symptoms or health 
problems to look out for after leaving the hospital?   
All “yes” except 1 “no” in 
MiH group 
p = >0.99	  
Before your child left the hospital, did you get information 
in writing about what symptoms or health problems to look 
out for after your child left the hospital?   
All “yes” except 1 “no” in 
MiH group 
p = >0.99	  
Using any number from 0 to 10, where 0 is the worst 
hospital possible and 10 is the best hospital possible, what 
number would you use to rate this hospital during your 
child's stay? 
Mean responses: 
UC: 9.1 
MiH: 8.8 
 
p = 0.64	  
Would you recommend this hospital to your friends and 
family?   
All “definitely yes” except 
two “probably yes” in MiH 
group 
p = 0.49	  
In general, how would you rate your child's overall health?  2/8 UC were “fair” while 
4/11 MiH were “fair.” The 
remainder were “good” or 
better. 
p = 0.68	  
To what extent does your child have symptoms of asthma 
right now, including cough, wheezing, difficulty breathing, 
or shortness of breath?  
Mean results: 
UC: 1.6 
MiH: 2.0 
 
[1=no symptoms, 2=few 
symptoms, 3=some 
symptoms] 
 
Only 27% of MiH 
responses were symptom-
free, while 50% of UC were 
symptom free 
p = 0.30	  
How much difficulty does your child have playing sports 
and keeping up with other children? 
Mean results:  
UC: 2.1 
p = 0.64	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MiH: 2.45 
 
[1=no difficulty; 2=almost 
no difficulty, 3=some 
difficulty,  
4=a lot of difficulty] 
How much difficulty does your child have doing all the 
necessary day-to-day tasks he/she normally does for 
him/herself? 
Mean results:  
UC: 2.0 
MiH: 1.5 
 
[1=no difficulty; 2=almost 
no difficulty, 3=some 
difficulty,  
4=a lot of difficulty] 
 
73% of MiH had “no 
difficulty” compared to 
50% for UC group 
p = 0.36	  
Has your child missed any school as a result of feeling not 
well in the time since leaving the hospital? 
73% of MiH had missed 
some school, compared to 
only 38% for UC group 
p = 0.15	  
Has your child missed any school in order to visit his/her 
doctor in the time since leaving the hospital? 
And only 3 of the 8 MiH 
patients missing school 
missed for a doctor’s visit 
p = 0.11	  
Have you seen a doctor for your child asthma since leaving 
the hospital? This can include a routine after-hospitalization 
follow-up visit with your primary care doctor 
1/8 UC had not seen their 
doctor, while 3/11 MiH 
patients had not seen a 
doctor 
p = 0.60	  
Have you seen a specialist for asthma since leaving the 
hospital? This would be a doctor who is a pulmonologist, or 
lung specialist. 
One patient from each arm 
had seen a specialist 
p = >0.99	  
Since leaving the hospital, have you been given a 
prescription for medications to help control your child's 
asthma that were not prescribed by the doctors taking care 
of him/her during the hospital stay? 
6/11 of MiH reported being 
given a new prescription, 
compared to 3/8 in the UC 
arm 
p = 0.65	  
Since leaving the hospital, have you had an unplanned 
doctors office visit or urgent care visit for your child's 
asthma? 
Two unplanned visits by 
MiH group 
p = 0.49	  
Since leaving the hospital, have you had to go to an ER for 
your child's asthma? 
All “no” 	  
Since leaving the hospital, has your child had to be admitted 
to a hospital for asthma? 
All “no” 	  
My records indicate that you received your child's 
medications before you left the hospital, is that correct? 
All “yes” (despite known 
crossover) 
	  
Do you feel you have all the medications your child needs? All “yes” 	  
Have you been giving the medications you received for your 
child at the times indicated by your doctor or pharmacist? 
All “yes” 	  
My records indicate that your medications were either sent 
electronically to your preferred pharmacy or given to you as 
a paper copy. At this point in time, have you picked up all 
the medications from your pharmacy? 
(UC-only question): 
 
1/8 had not picked up meds 
at time of call 
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Have you been giving the medications at the times indicated 
by your doctor or pharmacist? 
7/7 respondents said “yes” 	  
Do you have any questions about how to appropriately give 
your medications? 
All “no” 	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APPENDIX C: All comparisons for the thirty-day follow-up phone call 
 
Question Result/Comment Statistical Comparison 
Since you left the hospital, how many times have you seen 
your child's primary care doctor 
Result means:  
UC: 1.5 
MiH: 1.1 
 
Five UC patients with two 
or more visits, while two 
MiH with two or more 
visits (Fisher’s = 0.04) 
p = 0.44 
How many of those visits were within one week of being 
discharged from the hospital? 
Result means:  
UC: 0.9 
MiH: 1.0 
p = 0.66 
How many of those visits were for your child's asthma? Result means:  
UC: 1.3 
MiH: 1.0 
p = 0.42 
Since you left the hospital, how many times have you seen 
a pulmonologist, or lung specialist for your child's asthma 
Result means:  
UC: 0.5 
MiH: 0.9 
p = 0.54 
How many of those visits were within one week of being 
discharged from the hospital? 
Result means:  
UC: 0.3 
MiH: 0.7 
p = 0.52 
Since you left the hospital, how many times have you had 
an unplanned doctors visit or urgent care visit for your 
child's asthma 
Result means:  
UC: 0.4 
MiH: 0.3 
p = 0.89 
How many of those visits were within one week of being 
discharged from the hospital? 
Result means:  
UC: 0 
MiH: 0.5 
p = 0.27 
Since you left the hospital, how many times have you been 
to the ER for your child's asthma 
One visit for UC arm, 
none for MiH 
p = 0.12 
How many of those visits to the ER were within one week 
of being discharged from the hospital? 
None  
Since you left the hospital, how many times has your 
child's been admitted again to the hospital for his/her 
asthma? 
One admission for UC 
arm, none for MiH 
 
p = 0.35 
How many of those admissions were within one week of 
being discharged from the hospital? 
None 
 
 
In general, how would you rate your child's overall health?  Result means:  
UC: 2.6 
MiH: 2.2 
 
[1=excellent,  
2=very good,  
3=good,  
4=fair] 
p = 0.53 
Do you think your child is suffering from any pain or 
discomfort right now? 
The only child reportedly 
in pain was in the UC 
group 
p = 0.47 
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How much difficulty does your child have playing sports 
and keeping up with other children? 
Result means:  
UC: 1.0 
MiH: 1.11 
 
[0=no difficulty; 1=almost 
no difficulty; 2=some 
difficulty;  
3=a lot of difficulty] 
p = 0.84 
How much difficulty does your child have doing all the 
necessary day-to-day tasks they normally do for themselves 
Result means:  
UC: 1.0 
MiH: 0.4 
 
[0=no difficulty; 1=almost 
no difficulty; 2=some 
difficulty;  
3=a lot of difficulty] 
p = 0.26 
has your child missed any school because of feeling not 
well in the time since leaving the hospital? 
Result means (yes): 
3 children in UC arm,  
5 children in MiH arm 
 
p = 0.48 
How many days has s/he missed? (of those with any missed 
school days) 
Result means:  
UC: 2.0  
MiH: 7.6 
 
Large difference likely 
due to an MiH outlier 
reporting 20 days missed 
p = 0.37 
Has your child missed any school because of visiting the 
doctor in the time since leaving the hospital? 
Result means (yes):  
2 children in UC arm 
3 children in MiH arm 
p = >0.99 
Have you picked up any refill medications that were 
written for by your doctors in the hospital? 
3/8 UC say “yes” 
9/9 MiH say “yes” 
p = 0.08 
Did you have or do you think you will have any problems 
picking up these refills? 
Only family that had 
trouble picking up refills 
was in the UC group 
p = p=0.47 
Since returning from the hospital, have you made any 
changes to the home environment to try to improve your 
child's asthma? 
4/8 UC say “yes” 
2/9 MiH say “yes” 
p = 0.33  
What changes have you made to improve the home 
environment? 
UC: “cut down on smoking,” “patient 
doesn’t go to his dad’s as often, since he 
smokes cigarettes there,” “dusting,” “we 
bought an AC” 
MiH: “I got rid of my four cats,” “now he 
sleeps in his own room, where its not as 
messy.”    
Since leaving the hospital, have you had anyone visit your 
home to try to make your child's asthma less severe? This 
person could be a community health worker or a nurse. 
2/8 UC say “yes” 
2/9 MiH say “yes” 
p = >0.99 
Composite Asthma Control Test score Result means:  
UC: 18.38 
MiH: 17.33 
 
p = 0.62 
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Scores le 19 are 
considered “in control.”  
 
(when dichotomized to 
into or out of contro, 
Fisher’s p=0.33) 
My records indicate that your medications were either sent 
electronically to your preferred pharmacy or given to you 
as a paper copy. At this point in time, have you picked up 
all the medications prescribed to you before you left the 
hospital from your pha 
All meds picked up by UC 
group by 30 days 
 
Have you been giving your child's medications at the times 
prescribed by your doctor or pharmacist? 
Every subject says “yes”  
Do you have any questions about how to appropriately give 
your medications? 
Only family with a 
question was in UC group, 
but never called the MD 
whose number they were 
given 
p = 0.47 
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